News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Actavis to Shut Down Plants Until Issues Fixed
January 9, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Generic drugmaker Actavis has agreed to shut down several plants in New Jersey until they meet U.S. quality standards for the testing and manufacturing of pharmaceuticals.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Layoff Tracker
Gilead guts Arcellx team as BioNTech plant closures will wipe out 1,860 jobs
May 6, 2026
·
49 min read
·
BioSpace Editorial Staff
Podcast
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening
May 6, 2026
·
1 min read
·
Heather McKenzie
Earnings
Pfizer is a 2029 story but Q126 lays foundation for growth
May 5, 2026
·
3 min read
·
Annalee Armstrong
Layoffs
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
May 5, 2026
·
2 min read
·
Nick Paul Taylor
